ClinicalTrials.gov
ClinicalTrials.gov Menu

The Safety,Preliminary Pharmacodynamics and Pharmacokinetics Study of rExenatide-4 in Chinese Type 2 Diabetes Mellitus (SPPS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01342042
Recruitment Status : Unknown
Verified April 2011 by CSPC ZhongQi Pharmaceutical Technology Co., Ltd..
Recruitment status was:  Recruiting
First Posted : April 26, 2011
Last Update Posted : April 26, 2011
Sponsor:
Collaborators:
Peking University People's Hospital
Peking University First Hospital
Information provided by:
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : December 2011
  Estimated Study Completion Date : December 2011